Consequences of ADHD medication use for children's outcomes

Journal of Health Economics

Volumn 37, Issue 1, 2014, Pages 137-151

  Dalsgaard, Søren ^a   Nielsen, Helena Skyt ^a   Simonsen, Marianne ^a  

^a AARHUS UNIVERSITY   (Denmark)

Author keywords

Attention deficit hyperactivity disorder; Crime; Health; Hospital variation; Treatment

Indexed keywords

AMPHETAMINE; ATOMOXETINE; METHYLPHENIDATE; CENTRAL STIMULANT AGENT;

CHILD HEALTH; CRIME; DRUG; HEALTH CARE; HUMAN CAPITAL; MEDICINE;

ARTICLE; ATTENTION DEFICIT DISORDER; CLINICAL EVALUATION; DISEASE SEVERITY; EARLY DIAGNOSIS; ELEVATED BLOOD PRESSURE; HOSPITALIZATION; HUMAN; INSOMNIA; INTERNATIONAL CLASSIFICATION OF DISEASES; LOSS OF APPETITE; ONSET AGE; OUTCOME ASSESSMENT; PHYSICIAN ATTITUDE; PRESCRIPTION; TREATMENT INDICATION; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CHILD; CLINICAL PRACTICE; DENMARK; ECONOMICS; FEMALE; INFANT; MALE; PRESCHOOL CHILD; REGISTER; STATISTICS AND NUMERICAL DATA;

ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CENTRAL NERVOUS SYSTEM STIMULANTS; CHILD; CHILD, PRESCHOOL; DENMARK; DRUG PRESCRIPTIONS; FEMALE; HUMANS; INFANT; MALE; OUTCOME ASSESSMENT (HEALTH CARE); PRACTICE PATTERNS, PHYSICIANS'; REGISTRIES;

EID: 84903560196     PISSN: 01676296     EISSN: 18791646     Source Type: Journal    
DOI: 10.1016/j.jhealeco.2014.05.005     Document Type: Article

References (45)

1. Bilenberg N. The Child Behavior Checklist (CBCL) and related material: standardization and validation in Danish popuation based and clinically based samples. Acta Psychiatrica Scandinavica 1999, 100:2.
2. Blundell, Costa Dias Alternative approaches to evaluation in empirical microeconomics. Journal of Human Resources 2009, 44:565-640.
3. Coleman J., Katz E., Menzel H. The diffusion of an innovation among physicians. Sociometry 1957, 20(4):253-270.
4. Cunha F., Heckman J., Lochner L., Masterov D. Interpreting the evidence on life cycle skill formation. The Handbook of the Economics of Education 2006, North Holland, New York. E.A. Hanushek, F. Welch (Eds.).
5. Cunha F., Heckman J. The technology of skill formation. The American Economic Review (Papers and Proceedings) 2007, 97:31-47.
6. Currie J. Inequality at birth. Some causes and consequences. The American Economic Review (Papers and Proceedings) 2011, 101:1-22. 10.1257/aer.101.3.1.
7. Currie J., Almond D. Human capital development before age five. The Handbook of Labor Economics 2010, vol. 4b. Elsevier, Berkeley. 10.1016/S0169-7218(11)02413-0.
8. Currie J., Stabile M. Child mental health and human capital accumulation: the case of ADHD. Journal of Health Economics 2006, 25:1094-1118.
9. Currie J., Stabile M., Jones L.E. Do stimulant medications improve educational and behavioral outcomes for children with ADHD? NBER working paper 2013, 19105.
10. Dalsgaard S., Humlum M.K., Nielsen H.S., Simonsen M. Relative standards in ADHD diagnoses: the role of specialist behavior. Economics Letters 2012, 117:663-665. 10.1016/j.econlet.2012.08.008.
11. Dalsgaard S., Humlum M.K., Nielsen H.S., Simonsen M. Common Danish standards in prescribing medication for children and adolescents with ADHD. European Child and Adolescent Psychiatry 2013, 10.1007/s00787-013-0508-5.
12. Dalsgaard S., Leckman J.F., Nielsen H.S., Simonsen M. Gender and injuries predict stimulant medication. Journal of Child and Adolescent Psychopharmacology 2014, 24(5). 10.1089/cap.2013.0101.
13. Dalsgaard S., Mortensen P.B., Frydenberg M., Thomsen P.H. Conduct problems, gender and adult psychiatric outcome of children with attention-deficit hyperactivity disorder. British Journal of Psychiatry 2002, 181:416-421.
14. Ding W., Lehrer S., Rosenquist N., Audrain-McGovern J. The impact of poor health on academic performance: new evidence using genetic markers. Journal of Health Economics 2009, 28:578-597.
15. Doyle J. Child protection and child outcomes: measuring the effects of foster care. American Economic Review 2007, 97:1583-1610.
16. Doyle J. Child protection and adult crime: using investigator assignment to estimate causal effects of foster care. Journal of Political Economy 2008, 116:746-770.
17. Duggan M. Do new prescription drugs pay for themselves? The case of second-generation antipsychotics. Journal of Health Economics 2005, 24(1):31.
18. Elder T.E. The importance of relative standards in ADHD diagnoses: evidence based on exact birth dates. Journal of Health Economics 2010, 29:641-656. 10.1016/j.jhealeco.2010.06.003.
19. Evans W.N., Morrill M.S., Parente S.T. Measuring excess medical diagnosis and treatment in survey data: the case of ADHD among school-age children. Journal of Health Economics 2010, 29:657-673. 10.1016/j.jhealeco.2010.07.005.
20. Faraone S.V., Doyle A.E. The nature and heritability of attention deficit/hyperactivity disorder. Child and Adolescent Psychiatric Clinics of North America 2001, 10:299-309.
21. Faraone S.V., Sergeant J., Gillberg C., Biederman J. The worldwide prevalence of ADHD: is it an American condition?. World Psychiatry 2003, 2:104-113.
22. Fletcher J., Wolfe B. Child mental health and human capital accumulation: the case of ADHD revisited. Journal of Health Economics 2008, 27:794-800.
23. Frazier T.W., Demaree H.A., Youngstrom E.A. Meta-analysis of intellectual and neuropsychological test performance in attention-deficit/hyperactivity disorder. Neuropsychology 2004, 18:543-555.
24. Jensen P.S., Hinshaw S.P., Kraemer H.C., et al. ADHD comorbidity findings from the MTA study: comparing comorbid subgroups. Journal of the American Academy of Child and Adolescent Psychiatry 2001, 40:147-158.
25. Kvist A.P., Nielsen H.S., Simonsen M. The importance of children's ADHD for parents' relationship stability and labor supply. Social Science and Medicine 2013, 88:30-38. 10.1016/j.socscimed.2013.04.001.
26. Lechner M. The estimation of causal effects by difference-in-difference methods. Foundations and Trends in Econometrics 2011, 4(3):165-224. 10.1561/0800000014.
27. Lichtenstein P., Halldner L., Zetterqvist J., Sjölander A., Serlachius E., Fazel S., Långström N., Larsson H. Attention deficit hyperactivity disorder medication and criminality. New England Journal of Medicine 2012, 367:2006-2014. 10.1056/NEJMoa1203241.
28. Linnet K.M., Dalsgaard S., Obel C., et al. Maternal lifestyle factors in pregnancy risk of attention deficit hyperactivity disorder and associated behaviors: review of the current evidence. Journal of Psychiatry 2003, 160(6):1028-1040.
29. Linnet K.M., Wisborg K., Secher N.J., Thomsen P.H., Obel C., Dalsgaard S., Henriksen T.B. Coffee consumption during pregnancy and the risk of hyperkinetic disorder and ADHD: a prospective cohort study. Acta Paediatrica 2009, 98(1):173-179.
30. Maestas N., Mullen K.J., Strand A. Does disability insurance receipt discourage work? Using examiner assignment to estimate causal effects of SSDI receipt. American Economic Review 2013, 103(5):1797-1829. 10.1257/aer.103.5.1797.
31. Mannuzza S., Klein R. Long-term prognosis in attention-deficit/hyperactivity disorder. Child and Adolescent Psychiatric Clinics of North America 2000, 9:711-726.
32. Marcus S.C., Wan G.J., Zhang H.F., Olfson M. Injury among stimulant-treated youth with ADHD. Journal of Attention Disorders 2008, 12(1):64-69.
33. Mendez L., Singh P., Harrison G., Huang Y.-S., Jin X., Cho S.C. Academic outcomes in Asian children aged 8-11 years with attention-deficit/hyperactivity disorder treated with atomoxetine hydrochloride. International Journal of Psychiatry in Clinical Practice 2011, 15:145-156.
34. Molina B.S., Hinshaw S.P., Swanson J.M., et al. The MTA at 8 years: prospective follow-up of children treated for combined-type ADHD in a multisite study. Journal of the American Academy of Child and Adolescence Psychiatry 2009, 48:484-500.
35. MTA Cooperative Group A 14-month randomized clinical trial of treatment strategies for attention-deficit hyperactivity disorder. Archives of General Psychiatry 1999, 56:1073-1086.
36. MTA Cooperative Group 24-month outcomes of treatment strategies for attention-deficit/hyperactivity disorder. Pediatrics 2004, 113:754-763.
37. Munk-Jørgensen P., Mortensen P.B. The Danish psychiatric central register. Danish Medical Bulletin 1997, 44:82-84.
38. Obel C., Olsen J., Henriksen T.B., et al. Is maternal smoking during pregnancy a risk factor for hyperkinetic disorder? - findings from a sibling design. International Journal of Epidemiology 2011, 40:338-345. 10.1093/ije/dyq185.
39. Paykina N., Greenhill L. Attention deficit hyperactivity disorder. Clinical Manual of Child and Adolescent Psychopharmacology 2008, American Psychiatric Publishing, Washington, DC. R. Findling (Ed.).
40. Solanto M.V. Neuropsychopharmacological mechanisms of stimulant drug action in attention-deficit hyperactivity disorder: a review and integration. Behavioural Brain Research 1998, 94(1):127-152.
41. Soumerai S.B., McLaughlin T.J., Gurwitz J.H., Guadagnoli E., Hauptman P.J., Borbas C., Morris N., McLaughlin B., Gao X., Wilson D.J., Asinger R., Gobel F. Effect of local medical opinion leaders on quality of care for acute myocardial infarction: a randomized controlled trial. Journal of the American Medical Association 1998, 6(17):1358-1363.
42. Sroufe L.A. Ritalin gone wrong. New York Times 2012, (January 29).
43. The Danish Association for Child and Adolescent Psychiatry Reference Program for Diagnosing and Treating Children and Adolescents with ADHD 2008.
44. van der Oord S., Prins P.J., Oosterlaan J., Emmelkamp P.M. Efficacy of methylphenidate, psychosocial treatments and their combination in school-aged children with ADHD: a meta analysis. Clinical and Psychological Review 2008, 28(5):783-800.
45. WHO The ICD-10 Classification of Mental and Behavioural Disorders: Diagnostic Criteria for Research 1993, World Health Organization.